Adjudicating claims for COVID-19 vaccines, their administration and COVID-19 monoclonal antibodies

Medicare Advantage

 

Adjudicating claims for COVID-19 vaccines, their administration and COVID-19 monoclonal antibodies

 

Beginning January 1, 2022, Medicare Advantage Organizations (MAOs) and Medicare-Medicaid Plans

(MMPs) are responsible for adjudicating claims for COVID-19 vaccines and their administration and for

COVID-19 monoclonal antibodies and their administration. 

 

ABSCRNU-0286-21